← Evidence map

ArticleKidney international2021

Bortezomib plus dexamethasone for rituximab-resistant PLA2R

Sofiane Salhi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34420663